Vascular tissue engineering: Polymers and methodologies for small caliber vascular grafts
BBJ Leal, N Wakabayashi, K Oyama… - Frontiers in …, 2021 - frontiersin.org
Cardiovascular disease is the most common cause of death in the world. In severe cases,
replacement or revascularization using vascular grafts are the treatment options. While …
replacement or revascularization using vascular grafts are the treatment options. While …
Polymer-based or polymer-free stents in patients at high bleeding risk
S Windecker, A Latib, E Kedhi, AJ Kirtane… - … England Journal of …, 2020 - Mass Medical Soc
Background Polymer-free drug-coated stents provide superior clinical outcomes to bare-
metal stents in patients at high bleeding risk who undergo percutaneous coronary …
metal stents in patients at high bleeding risk who undergo percutaneous coronary …
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the …
comprehensive review of the published evidence for management of a given condition
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …
according to ESC Committee for Practice Guidelines (CPG) policy. A critical evaluation of …
Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM follow-on study
ME Farkouh, M Domanski, GD Dangas… - Journal of the American …, 2019 - jacc.org
Abstract Background: The FREEDOM (Future Revascularization Evaluation in Patients with
Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated that for …
Diabetes Mellitus: Optimal Management of Multivessel Disease) trial demonstrated that for …
Cardiac mortality in patients randomised to elective coronary revascularisation plus medical therapy or medical therapy alone: a systematic review and meta-analysis
EP Navarese, AJ Lansky, DJ Kereiakes… - European heart …, 2021 - academic.oup.com
Aims The value of elective coronary revascularisation plus medical therapy over medical
therapy alone in managing stable patients with coronary artery disease is debated. We …
therapy alone in managing stable patients with coronary artery disease is debated. We …
P2Y12 inhibitor monotherapy in patients undergoing percutaneous coronary intervention
For 20 years, dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a
platelet P2Y12 receptor inhibitor, has been the gold standard of antithrombotic …
platelet P2Y12 receptor inhibitor, has been the gold standard of antithrombotic …
Evolocumab for early reduction of LDL cholesterol levels in patients with acute coronary syndromes (EVOPACS)
KC Koskinas, S Windecker, G Pedrazzini… - Journal of the American …, 2019 - jacc.org
Background: Although guidelines recommend in-hospital initiation of high-intensity statin
therapy in patients with acute coronary syndromes (ACS), low-density lipoprotein cholesterol …
therapy in patients with acute coronary syndromes (ACS), low-density lipoprotein cholesterol …
Aspirin versus clopidogrel for long-term maintenance monotherapy after percutaneous coronary intervention: the HOST-EXAM extended study
J Kang, KW Park, H Lee, D Hwang, HM Yang… - Circulation, 2023 - Am Heart Assoc
Background: Long-term outcomes of antiplatelet monotherapy in patients who receive
percutaneous coronary intervention are unknown. The HOST-EXAM (Harmonizing Optimal …
percutaneous coronary intervention are unknown. The HOST-EXAM (Harmonizing Optimal …
Five-year outcomes after state-of-the-art percutaneous coronary revascularization in patients with de novo three-vessel disease: final results of the SYNTAX II study
AP Banning, P Serruys, GL De Maria… - European Heart …, 2022 - academic.oup.com
Abstract Aims The SYNTAX II study evaluated the impact of advances in percutaneous
coronary intervention (PCI), integrated into a single revascularization strategy, on outcomes …
coronary intervention (PCI), integrated into a single revascularization strategy, on outcomes …
EAPCI position statement on invasive management of acute coronary syndromes during the COVID-19 pandemic
Abstract The coronavirus disease 2019 (COVID-19) pandemic poses an unprecedented
challenge to healthcare worldwide. The infection can be life threatening and require …
challenge to healthcare worldwide. The infection can be life threatening and require …